ICM
NTUS

Invenomic Capital Management’s Natus Medical Inc NTUS Stock Holding History

Invenomic Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-121,061
Closed -$2.47M – 198
2022
Q1 		$2.47M Buy
121,061
+50,028
+70% +$1.22M 0.26% 90
2021
Q4 		$1.69M Buy
+71,033
New +$1.75M 0.36% 81
2021
Q1 		– Sell
-50,252
Closed -$1.01M – 169
2020
Q4 		$1.01M Buy
+50,252
New +$984K 0.26% 72

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invenomic Capital Management's NTUS Position: Q2 2022 in Review

Invenomic Capital Management sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 121,061 shares — an estimated $2.47M sold.

Invenomic Capital Management first reported a position in NTUS in Q4 2020 and held it in 3 quarters. The position peaked at $2.47M in Q1 2022. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Invenomic Capital Management reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 121,061 Natus Medical Inc shares in Q2 2022, an estimated $2.47M.
  • Invenomic Capital Management first reported a position in Natus Medical Inc in Q4 2020 and held it in 3 quarters.
  • Invenomic Capital Management's Natus Medical Inc position peaked at $2.47M in Q1 2022.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Invenomic Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.